AxoGen, Inc. (0HKD.L)

USD 15.38

(-6.11%)

Long Term Debt Summary of AxoGen, Inc.

  • AxoGen, Inc.'s latest annual long term debt in 2023 was 46.6 Million USD , down -29.51% from previous year.
  • AxoGen, Inc.'s latest quarterly long term debt in 2024 Q2 was 47.04 Million USD , up 0.47% from previous quarter.
  • AxoGen, Inc. reported annual long term debt of 66.11 Million USD in 2022, up 0.76% from previous year.
  • AxoGen, Inc. reported annual long term debt of 65.61 Million USD in 2021, up 24.04% from previous year.
  • AxoGen, Inc. reported quarterly long term debt of 46.82 Million USD for 2024 Q1, up 0.48% from previous quarter.
  • AxoGen, Inc. reported quarterly long term debt of 66.3 Million USD for 2023 Q3, up 0.03% from previous quarter.

Annual Long Term Debt Chart of AxoGen, Inc. (2023 - 1989)

Created with Highcharts 11.1.0YearsLong Term Debt199019921994199619982000200220042006200820102012201420162018202020220 USD20000000 USD40000000 USD60000000 USD80000000 USD

Historical Annual Long Term Debt of AxoGen, Inc. (2023 - 1989)

Year Long Term Debt Long Term Debt Growth
2023 46.6 Million USD -29.51%
2022 66.11 Million USD 0.76%
2021 65.61 Million USD 24.04%
2020 52.9 Million USD 3216.68%
2019 1.59 Million USD 4457.14%
2018 35 Thousand USD -99.82%
2017 19.9 Million USD -1.78%
2016 20.26 Million USD -20.67%
2015 25.54 Million USD 1.84%
2014 25.08 Million USD -1.1%
2013 25.36 Million USD 17.53%
2012 21.58 Million USD 390.04%
2011 4.4 Million USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD -100.0%
2003 62.43 Thousand USD 479.74%
2002 10.77 Thousand USD -91.4%
2001 125.17 Thousand USD 301.39%
2000 31.18 Thousand USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%
1997 - USD 0.0%
1996 - USD 0.0%
1995 - USD 0.0%
1994 - USD 0.0%
1993 - USD 0.0%
1992 - USD 0.0%
1991 - USD -100.0%
1990 800 Thousand USD -33.33%
1989 1.2 Million USD 200.0%

Peer Long Term Debt Comparison of AxoGen, Inc.

Name Long Term Debt Long Term Debt Difference
Phreesia, Inc. 2.04 Million USD -2174.427%
Accuray Incorporated 164.4 Million USD 71.653%
Align Technology, Inc. 96.96 Million USD 51.94%
Elevance Health Inc. 23.24 Billion USD 99.8%
Boston Scientific Corporation 8.56 Billion USD 99.456%
CVS Health Corporation 74.67 Billion USD 99.938%
Cardinal Health, Inc. 4.58 Billion USD 98.983%
Centene Corporation 17.69 Billion USD 99.737%
DaVita Inc. 8.05 Billion USD 99.421%
HCA Healthcare, Inc. 36.62 Billion USD 99.873%
Hologic, Inc. 2.49 Billion USD 98.134%
Humana Inc. 10.21 Billion USD 99.544%
IDEXX Laboratories, Inc. 622.88 Million USD 92.518%
Laboratory Corporation of America Holdings 4.05 Billion USD 98.851%
Masimo Corporation 871.7 Million USD 94.654%
McKesson Corporation 5.45 Billion USD 99.145%
Patterson Companies, Inc. 328.91 Million USD 85.831%
Quest Diagnostics Incorporated 4.41 Billion USD 98.943%
ResMed Inc. 697.31 Million USD 93.317%
Henry Schein, Inc. 1.93 Billion USD 97.589%
Teladoc Health, Inc. 1.58 Billion USD 97.053%
Universal Health Services, Inc. 4.71 Billion USD 99.012%
Veeva Systems Inc. 46.44 Million USD -0.349%
Baxter International Inc. 11.06 Billion USD 99.579%
Becton, Dickinson and Company 14.73 Billion USD 99.684%
Intuitive Surgical, Inc. -82.1 Million USD 156.764%
Danaher Corporation 17.66 Billion USD 99.736%
Stryker Corporation 10.9 Billion USD 99.572%
Medtronic plc 23.87 Billion USD 99.805%